Viewing Study NCT03129061


Ignite Creation Date: 2025-12-24 @ 11:59 AM
Ignite Modification Date: 2026-01-29 @ 11:54 PM
Study NCT ID: NCT03129061
Status: COMPLETED
Last Update Posted: 2022-12-05
First Post: 2017-04-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Sponsor: CellSight Technologies, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module